Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies

被引：53
作者：
Gibb, Jean [1 ]
Wong, Darren W. [1 ]
机构：
[1] Univ Southern Calif USC, Keck Sch Med, Div Infect Dis, Los Angeles, CA 90033 USA
来源：
ANTIBIOTICS-BASEL | 2021年 / 10卷 / 10期
关键词：
Stenotrophomonas; Stenotrophomonas maltophilia; treatment; cefiderocol; avibactam; aztreonam; IN-VITRO ACTIVITY; TRIMETHOPRIM-SULFAMETHOXAZOLE; COMBINATION THERAPY; SUSCEPTIBILITY; TIGECYCLINE; INFECTIONS; MONOTHERAPY; MINOCYCLINE; PNEUMONIA; COLISTIN;
D O I：
10.3390/antibiotics10101226
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Stenotrophomonas maltophilia is an urgent global threat due to its increasing incidence and intrinsic antibiotic resistance. Antibiotic development has focused on carbapenem-resistant Enterobacteriaceae, Pseudomonas, and Acinetobacter, with approved antibiotics in recent years having limited activity for Stenotrophomonas. Accordingly, novel treatment strategies for Stenotrophomonas are desperately needed. We conducted a systemic literature review and offer recommendations based on current evidence for a treatment strategy of Stenotrophomonas infection.
引用
收藏
页数：14
相关论文
共 84 条
[1]  
Alexander J., 2020, Open Forum Infect Diseases, V7, P798, DOI [10.1093/ofid/ofaa439.1787, DOI 10.1093/OFID/OFAA439.1787]
[2]   Comparative Activities of Tigecycline and Other Tetracyclines against Nonfermenting Gram-Negative Bacilli, Excluding Acinetobacter spp. [J].
Almuzara, Marisa N. ;
Encalada Barzallo, Maria Isabel ;
Famiglietti, Angela M. R. ;
Vay, Carlos A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (08) :3961-3963
[3]   Early Experience With Eravacycline for Complicated Infections [J].
Alosaimy, Sara ;
Molina, Kyle C. ;
Claeys, Kimberly C. ;
Andrade, Justin ;
Truong, James ;
King, Madeline A. ;
Pullinger, Benjamin M. ;
Huang, Glen ;
Morrisette, Taylor ;
Lagnf, Abdalhamid M. ;
Davis, Susan L. ;
Rybak, Michael J. .
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05)
[4]   Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients [J].
Araoka, Hideki ;
Baba, Masaru ;
Okada, Chikako ;
Abe, Masahiro ;
Kimura, Muneyoshi ;
Yoneyama, Akiko .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 58 :18-21
[5]   Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model [J].
Ba, BB ;
Feghali, H ;
Arpin, C ;
Saux, MC ;
Quentin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :946-953
[6]   Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial [J].
Bassetti, Matteo ;
Echols, Roger ;
Matsunaga, Yuko ;
Ariyasu, Mari ;
Doi, Yohei ;
Ferrer, Ricard ;
Lodise, Thomas P. ;
Naas, Thierry ;
Niki, Yoshihito ;
Paterson, David L. ;
Portsmouth, Simon ;
Torre-Cisneros, Julian ;
Toyoizumi, Kiichiro ;
Wunderink, Richard G. ;
Nagata, Tsutae D. .
LANCET INFECTIOUS DISEASES, 2021, 21 (02) :226-240
[7]   Activity of colistin in combination with tigecycline or rifampicin against multidrug-resistant Stenotrophomonas maltophilia [J].
Betts, J. W. ;
Phee, L. M. ;
Woodford, N. ;
Wareham, D. W. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2014, 33 (09) :1565-1572
[8]   Activity of Aztreonam in Combination with Avibactam, Clavulanate, Relebactam, and Vaborbactam against Multidrug-Resistant Stenotrophomonas maltophilia [J].
Biagi, M. ;
Lamm, D. ;
Meyer, K. ;
Vialichka, A. ;
Jurkovic, M. ;
Patel, S. ;
Mendes, R. E. ;
Bulman, Z. P. ;
Wenzler, E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)
[9]   Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia [J].
Biagi, M. ;
Vialichka, A. ;
Jurkovic, M. ;
Wu, T. ;
Shajee, A. ;
Lee, M. ;
Patel, S. ;
Mendes, R. E. ;
Wenzler, E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
[10]   Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole [J].
Biagi, M. ;
Tan, X. ;
Wu, T. ;
Jurkovic, M. ;
Vialichka, A. ;
Meyer, K. ;
Mendes, R. E. ;
Wenzler, E. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (02)
123456789